News | July 31, 2025
Asahi Kasei Life Science to construct new plant for Planova virus removal filters
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Subscribe To Our Newsletter & Stay Updated
